Skin complications of HIV infection

Infection with HIV leads to a decrease in cell-mediated immunity resulting in a variety of opportunistic infections of viral, bacterial and fungal etiology. Cutaneous manifestations of infectious and noninfectious causes are frequently reported in HIV patients. Some infectious diseases, such as herpes simplex, herpes zoster, human papillomavirus, bacterial folliculitis and dermatophytosis, are commonly observed in the general population but may have a severe or recalcitrant course in HIV/AIDS patients. Other diseases, such as bacillary angiomatosis and disseminated fungal infections, are rare and limited to immunocompromised individuals. With the advent of highly active antiretroviral therapy in the 1990s, drug reactions have become more frequent. HIV/AIDS patients can have reactions to antiretroviral medications, including a morbilliform rash, urticaria, Stevens–Johnson syndrome and drug hypersensitivity syndrome.

[1]  Elizabeth J Horn,et al.  A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach. , 2009, Journal of the American Academy of Dermatology.

[2]  C. Borrás,et al.  Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection. , 2008, The Journal of antimicrobial chemotherapy.

[3]  G. Chêne,et al.  Evolving epidemiology of malignancies in HIV , 2008, Current opinion in oncology.

[4]  L. Lynen,et al.  Prevention and treatment of the immune reconstitution inflammatory syndrome , 2008, Current opinion in HIV and AIDS.

[5]  Scott Rose,et al.  Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[6]  R. Brodell,et al.  The treatment of herpes simplex infections: an evidence-based review. , 2008, Archives of internal medicine.

[7]  S. Tyring,et al.  Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older. , 2008, The Journal of infectious diseases.

[8]  S. Tyring,et al.  Family history as a risk factor for herpes zoster: a case-control study. , 2008, Archives of dermatology.

[9]  R. Aly,et al.  The prevalence of dermatophyte infection in patients infected with human immunodeficiency virus , 2008, International journal of dermatology.

[10]  Mahnaz Fatahzadeh,et al.  Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. , 2007, Journal of the American Academy of Dermatology.

[11]  A. Gewirtzman,et al.  Dermatological management of human immunodeficiency virus (HIV). , 2007, Skin therapy letter.

[12]  S. Tyring,et al.  Managing herpes zoster in immunocompromised patients. , 2007, Herpes : the journal of the IHMF.

[13]  D. Rosmarin,et al.  Toxic epidermal necrolysis. , 2007, Journal of the American Academy of Dermatology.

[14]  M. Glesby,et al.  Dermatologic Adverse Effects of Antiretroviral Therapy , 2007, American journal of clinical dermatology.

[15]  C. Martins Cutaneous drug reactions associated with newer antiretroviral agents. , 2006, Journal of drugs in dermatology : JDD.

[16]  R. Watanabe,et al.  Treatment of HIV‐associated eosinophilic pustular folliculitis with narrow‐band UVB , 2006, International journal of dermatology.

[17]  G. Meintjes,et al.  Dermatologic manifestations of the immune reconstitution inflammatory syndrome. , 2006, Dermatologic clinics.

[18]  Molly T Hogan Cutaneous infections associated with HIV/AIDS. , 2006, Dermatologic clinics.

[19]  S. Eisman Pruritic papular eruption in HIV. , 2006, Dermatologic clinics.

[20]  R. Schwartz,et al.  Eosinophilic pustular folliculitis: a 40 year retrospect. , 2006, Journal of the American Academy of Dermatology.

[21]  R. Nguyen,et al.  Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. , 2006, Journal of the American Academy of Dermatology.

[22]  D. Raoult,et al.  Bartonella quintana Characteristics and Clinical Management , 2006, Emerging infectious diseases.

[23]  S. Shelburne,et al.  Immune reconstitution inflammatory syndrome: more answers, more questions. , 2006, The Journal of antimicrobial chemotherapy.

[24]  P. Easterbrook,et al.  Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  Richard J Hayes,et al.  Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies , 2006, AIDS.

[26]  C. McCall,et al.  Eosinophilic Folliculitis in HIV-Infected Women , 2006 .

[27]  J. Saurat,et al.  Topical tacrolimus for effective treatment of eosinophilic folliculitis associated with human immunodeficiency virus infection. , 2005, Archives of dermatology.

[28]  T. Maurer,et al.  Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy. , 2005, Archives of dermatology.

[29]  S. Tyring,et al.  Advances in antiviral therapy. , 2005, Dermatologic clinics.

[30]  J. Perfect,et al.  Evaluation and management of Fungal infections in Immunocompromised patients , 2005, Dermatologic therapy.

[31]  H. Kong,et al.  Cutaneous effects of highly active antiretroviral therapy in HIV‐infected patients , 2005, Dermatologic therapy.

[32]  A. Katsambas,et al.  Cutaneous markers of HIV infection. , 2004, Clinics in dermatology.

[33]  M. Levin,et al.  Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  V. Wiwanitkit Prevalence of dermatological disorders in Thai HIV‐infected patients correlated with different CD4 lymphocyte count statuses: a note on 120 cases , 2004, International journal of dermatology.

[35]  T. Sata,et al.  Hair follicle involvement in herpes zoster: pathway of viral spread from ganglia to skin , 1996, Virchows Archiv.

[36]  A. Milito B lymphocyte dysfunctions in HIV infection. , 2004 .

[37]  N. Scheinfeld,et al.  Eosinophilic Pustular Folliculitis , 2004 .

[38]  C. James,et al.  Enfuvirtide: A Novel Agent for the Treatment of HIV-1 Infection , 2003, The Annals of pharmacotherapy.

[39]  C. Burkhart,et al.  Tinea corporis in human immunodeficiency virus‐positive patients: case report and assessment of oral therapy , 2003, International journal of dermatology.

[40]  R. Sarisky,et al.  Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials , 2003, Archives of Virology.

[41]  J. Gnann Varicella-zoster virus: atypical presentations and unusual complications. , 2002, The Journal of infectious diseases.

[42]  S. Tyring,et al.  Antiviral agents: Nonantiviral drugs , 2002 .

[43]  S. Tyring,et al.  Verrucous herpes of the scrotum in a human immunodeficiency virus‐positive man: case report and review of the literature , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[44]  R. Whitley,et al.  Clinical practice. Herpes zoster. , 2002, The New England journal of medicine.

[45]  J. Arrese,et al.  Skin manifestations of Bartonella infections , 2002, International journal of dermatology.

[46]  S. Tyring,et al.  The cutaneous manifestations of HIV infection. , 2002, Dermatologic clinics.

[47]  T. M. Chen,et al.  Clinical manifestations of varicella-zoster virus infection. , 2002, Dermatologic clinics.

[48]  T. Horn,et al.  The histopathology of folliculitis in HIV‐infected patients , 2002, Journal of cutaneous pathology.

[49]  G. Russo,et al.  Cutaneous manifestations of antiretroviral therapy. , 2002, Journal of the American Academy of Dermatology.

[50]  A. Wald,et al.  Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. , 2002, The Journal of infectious diseases.

[51]  Eduardo Fonseca,et al.  Indinavir-Induced Retinoid-Like Effects , 2002, Drug safety.

[52]  J. Bingham,et al.  Dermatological immune restoration syndrome: does it exist? , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

[53]  N. Naing,et al.  Cutaneous manifestations in HIV positive patients. , 2001, The Southeast Asian journal of tropical medicine and public health.

[54]  P. Ljungman,et al.  A Randomized, Double-Blind Trial of Famciclovir Versus Acyclovir for the Treatment of Localized Dermatomal Herpes Zoster in Immunocompromised Patients , 2001, Cancer investigation.

[55]  M. Rinaldi,et al.  Dermatophytosis: Epidemiological and microbiological update , 2000 .

[56]  R. Johnson,et al.  Dermatophyte infections in human immune deficiency virus (HIV) disease. , 2000, Journal of the American Academy of Dermatology.

[57]  S. Tyring,et al.  Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. , 2000, Archives of family medicine.

[58]  B. Cochener,et al.  Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. , 2000, Ophthalmology.

[59]  S. Tyring,et al.  Cutaneous viral infections in HIV-infected individuals. , 2000, Clinics in dermatology.

[60]  J. Machadob,et al.  Bacillary angiomatosis by Bartonella quintana in an HIV-infected patient. , 2000 .

[61]  B. Rentier,et al.  Chronic verrucous varicella zoster virus skin lesions: clinical, histological, molecular and therapeutic aspects , 1999, Clinical and experimental dermatology.

[62]  Rowe,et al.  Itchy folliculitis and human immunodeficiency virus infection: clinicopathological and immunological features, pathogenesis and treatment , 1999, The British journal of dermatology.

[63]  S. Tyring,et al.  Herpes. Atypical clinical manifestations. , 1998, Dermatologic clinics.

[64]  D. Raoult,et al.  Bacillary angiomatosis in immunocompromised patients , 1998, AIDS.

[65]  T. Schacker,et al.  Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. , 1998, JAMA.

[66]  J. Kaldor,et al.  Herpes zoster and the stage and prognosis of HIV-1 infection. , 1997, Genitourinary medicine.

[67]  C. Darley,et al.  The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression , 1997, The British journal of dermatology.

[68]  S. Lee,et al.  A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS. , 1997, The Journal of infectious diseases.

[69]  J. Tappero,et al.  Bacillary angiomatosis and other Bartonella species infections. , 1997, Seminars in cutaneous medicine and surgery.

[70]  S. Vallurupalli,et al.  UVB phototherapy is an effective treatment for pruritus in patients infected with HIV. , 1997, Journal of the American Academy of Dermatology.

[71]  B. Elewski,et al.  Fungal infections in HIV-infected patients. , 1997, Seminars in cutaneous medicine and surgery.

[72]  R. Brettle Bacterial infections in HIV: the extent and nature of the problem , 1997, International journal of STD & AIDS.

[73]  C. Kemper,et al.  Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: clinical characteristics in a case-control study. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  J. Feldman,et al.  Increased Genital Shedding of Herpes Simplex Virus Type 2 in HIV-Seropositive Women , 1995, Annals of Internal Medicine.

[75]  K. Beutner,et al.  Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. , 1995, Antiviral research.

[76]  T. Maurer,et al.  Eosinophilic Folliculitis: The Histologic Spectrum , 1995, The American Journal of dermatopathology.

[77]  J. V. D. van der Meer,et al.  Herpes zoster, immunological deterioration and disease progression in HIV‐1 infection , 1995, AIDS.

[78]  C. Otley,et al.  Isotretinoin treatment of human immunodeficiency virus-associated eosinophilic folliculitis. Results of an open, pilot trial. , 1995, Archives of dermatology.

[79]  R. Chaisson,et al.  Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[80]  J. Tappero,et al.  Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus. , 1995 .

[81]  A. Sivayathorn,et al.  Prevalence of skin disease in patients infected with human immunodeficiency virus in Bangkok, Thailand. , 1995, Annals of the Academy of Medicine, Singapore.

[82]  D. Friedman,et al.  Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults , 1995, Antimicrobial agents and chemotherapy.

[83]  T. Berger,et al.  Itraconazole therapy for human immunodeficiency virus-associated eosinophilic folliculitis. , 1995, Archives of dermatology.

[84]  R. Stern,et al.  Cutaneous disease and drug reactions in HIV infection. , 1993, The New England journal of medicine.

[85]  Jennifer Y. Liu,et al.  Herpes zoster and human immunodeficiency virus infection. , 1992, The Journal of infectious diseases.

[86]  J. Palefsky,et al.  Chronic Verrucous Varicella‐Zoster Virus Infection in Patients with the Acquired Immunodeficiency Syndrome (AIDS): Histologic and Molecular Biologic Findings , 1992, The American Journal of dermatopathology.

[87]  P. Leboit,et al.  Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. , 1991, Archives of dermatology.

[88]  C. Cockerell,et al.  Bacillary angiomatosis: a newly characterized, pseudoneoplastic, infectious, cutaneous vascular disorder. , 1990, Journal of the American Academy of Dermatology.

[89]  Timothy G. Berger,et al.  Bacillary Angiomatosis: The Histopathology and Differential Diagnosis of a Pseudoneoplastic Infection in Patients with Human Immunodeficiency Virus Disease , 1989, The American journal of surgical pathology.

[90]  O. Laskin,et al.  Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndrome. , 1989, Journal of the American Academy of Dermatology.

[91]  R. Schinella,et al.  Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. Report of three cases. , 1986, Journal of the American Academy of Dermatology.

[92]  M. Stoler,et al.  An atypical subcutaneous infection associated with acquired immune deficiency syndrome. , 1983, American journal of clinical pathology.